<SEC-DOCUMENT>0001167379-21-000013.txt : 20210428
<SEC-HEADER>0001167379-21-000013.hdr.sgml : 20210428
<ACCEPTANCE-DATETIME>20210428172046
ACCESSION NUMBER:		0001167379-21-000013
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20210428
FILED AS OF DATE:		20210428
DATE AS OF CHANGE:		20210428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALCON INC
		CENTRAL INDEX KEY:			0001167379
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				980205094
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31269
		FILM NUMBER:		21865604

	BUSINESS ADDRESS:	
		STREET 1:		6201 SOUTH FREEWAY
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76134
		BUSINESS PHONE:		817 293 0450

	MAIL ADDRESS:	
		STREET 1:		CHEMIN DE BLANDONNET 8
		STREET 2:		1214 VERNIER
		CITY:			GENEVA
		STATE:			V8
		ZIP:			0000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6-kx42821.htm
<DESCRIPTION>6-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i03ef4095840c4517bace4c4b2441f46f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_________________</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:22pt;font-weight:700;line-height:120%">FORM 6-K </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_________________</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:13pt;font-weight:700;line-height:120%">REPORT OF FOREIGN PRIVATE ISSUER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:13pt;font-weight:700;line-height:120%">PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:13pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:700;line-height:120%">April 28, 2021</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Commission File Number&#58; 001-31269 </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_________________</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:22pt;font-weight:700;line-height:120%">ALCON INC. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant Name)</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chemin de Blandonnet 8</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <br></font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1214 Vernier, Geneva, Switzerland </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive office)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_________________</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20&#8209;F or Form 40-F&#58;  Form 20-F </font><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;Form 40-F </font><font style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)&#58; </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">         </font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)&#58; </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">         </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i03ef4095840c4517bace4c4b2441f46f_7"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:130%">EXHIBIT INDEX</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit<br>Number</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit991-form6xk428.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Press release issued by Alc</a></font><font style="background-color:#ffffff;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit991-form6xk428.htm" style="-sec-extract:exhibit;background-color:#ffffff;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">on Inc. dated April 28, 2021 titl</a></font><font style="color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit991-form6xk428.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ed &#8220;</a><a href="exhibit991-form6xk428.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Alcon</a><a href="exhibit991-form6xk428.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> </a><a href="exhibit991-form6xk428.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop </a></font><font style="color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit991-form6xk428.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Simbrinza</a></font><font style="color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit991-form6xk428.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221;</a></font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><div id="i03ef4095840c4517bace4c4b2441f46f_10"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:4.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ALCON INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 28, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Timothy C. Stonesifer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Timothy C. Stonesifer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Authorized Representative</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 28, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Royce Bedward</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Royce Bedward</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Authorized Representative</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-indent:288pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991-form6xk428.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3ce145ef39a44c57920197448238ad87_109"></div><div style="min-height:0pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><img alt="logopressrelease2a011.jpg" src="logopressrelease2a011.jpg" style="height:294px;margin-bottom:5pt;vertical-align:text-bottom;width:816px"></div><div id="i3ce145ef39a44c57920197448238ad87_1"></div><div style="padding-right:-15.4pt"><font style="color:#003595;font-family:'Open Sans',sans-serif;font-size:17pt;font-weight:700;line-height:120%">Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop </font><font style="color:#003595;font-family:'Open Sans',sans-serif;font-size:17pt;font-style:italic;font-weight:700;line-height:120%">Simbrinza</font><font style="color:#003595;font-family:'Open Sans',sans-serif;font-size:17pt;font-weight:700;line-height:120%"><br></font></div><div style="padding-left:13.5pt;padding-right:-15.4pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.99pt">Expands Alcon&#8217;s existing portfolio and strengthens position in the ophthalmic eye drops market</font></div><div style="padding-left:13.5pt;padding-right:-15.4pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.99pt">Builds on company&#8217;s ophthalmic pharmaceutical manufacturing expertise</font></div><div style="padding-right:-15.4pt;text-align:justify"><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#00aeef;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Geneva, April 28, 2021 &#8211; </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alcon (SIX&#47;NYSE&#58; ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has signed an agreement to acquire exclusive U.S. commercialization rights to </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simbrinza</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(brinzolamide&#47;brimonidine tartrate ophthalmic suspension) 1%&#47;0.2%</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from Novartis. </font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition of </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simbrinza</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> combined with the company&#8217;s existing over-the-counter (OTC) eye drops will give Alcon a strong ophthalmic eye drop portfolio and the opportunity to capitalize on both the large glaucoma market and the fast-growing dry eye preservative free and eye allergy markets. The company&#8217;s strong U.S. ophthalmology expertise and existing relationships with healthcare professionals (HCP) will help drive HCP and patient adoption.</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simbrinza </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a fixed combination of a carbonic anhydrase inhibitor and an alpha-2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of these two components decreases elevated IOP. Elevated IOP is a major risk factor in the pathogenesis of optic nerve damage and glaucomatous visual field loss. </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simbrinza </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was initially approved by the U.S. FDA in 2013 and is covered by patents, which are not expected to expire until 2030.</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreement, after closing, Alcon and Novartis will immediately begin a transition period where Novartis will continue to sell </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simbrinza</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and transfer the net profit to Alcon. Following the transition period, Alcon expects to manufacture and commercialize </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simbrinza</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the U.S. market, while Novartis will retain all rights to </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simbrinza</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> outside of the U.S.  </font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;As the global leader in eye care, the addition of a proven fixed-combination glaucoma therapy is a natural adjacency to our existing portfolio,&#8221; said Sergio Duplan, President, North America at Alcon. </font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;We look forward to establishing a new commercial team dedicated to U.S. ophthalmologists that will promote our new products </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pataday</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Once Daily Relief Extra Strength</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="background-color:#ffffff;color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systane</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hydration Multi-Dose Preservative-Free</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and now </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simbrinza</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alcon separately today announced the U.S. launch of </font><font style="background-color:#ffffff;color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systane </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hydration Multi-Dose Preservative-Free</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (MDPF) Lubricant Eye Drops. The preservative-free formulation is now available in a multi-dose bottle designed to minimize microbial contamination.</font><font style="background-color:#ffffff;color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt"><font style="background-color:#ffffff;color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under terms of the agreement, Alcon will pay $355 million USD at closing, which is expected to occur in the second quarter of 2021.</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:132%">1&#47;3</font></div><div style="text-align:justify"><font><br></font></div></div></div><div id="i3ce145ef39a44c57920197448238ad87_130"></div><hr style="page-break-after:always"><div style="min-height:57pt;width:100%"><div><font><br></font></div></div><div style="padding-right:-15.4pt"><font style="color:#003595;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Forward-looking Statements</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This press release contains, and our officers and representatives may from time to time make, certain &#8220;forward-looking statements&#8221; within the meaning of the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as&#58; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;commitment,&#8221; &#8220;look forward,&#8221; &#8220;maintain,&#8221; &#8220;plan,&#8221; &#8220;goal,&#8221; &#8220;seek,&#8221; &#8220;target,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;strategy,&#8221; &#8220;future,&#8221; &#8220;likely,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;will&#8221; and similar references to future periods. Examples of forward-looking statements include, among others, statements Alcon makes regarding its plans and decisions relating to the acquisition, manufacture, distribution, marketing and&#47;or sale of </font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simbrinza</font><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; the ability of Alcon to execute on these plans&#59; market growth assumptions&#59; Alcon&#8217;s relationships with healthcare professionals&#59; and generally, its expectations concerning its future performance. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on Alcon&#8217;s current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict. Such forward-looking statements are subject to various risks and uncertainties facing Alcon, including&#58; the effect of the ongoing COVID-19 pandemic as well as other viral or disease outbreaks as well as the availability of vaccines&#59; the commercial success of its products and its ability to maintain and strengthen its position in its markets&#59; the success of its research and development efforts, including its ability to innovate to compete effectively&#59; its success in completing and integrating strategic acquisitions&#59; the possibility that various closing conditions for the transaction may not be satisfied or waived, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the transaction&#59; transaction costs&#59; its ability to successfully transition the manufacture, distribution and commercialization from Novartis after closing&#59; its ability to leverage existing relationships with healthcare professionals to help drive patient adoption&#59; pricing pressure from changes in third party payor coverage and reimbursement methodologies&#59; global and regional economic, financial, legal, tax, political, and social change&#59; data breaches or other disruptions of its information technology systems&#59; ongoing industry consolidation&#59; its ability to properly educate and train healthcare providers on its products&#59; changes in inventory levels or buying patterns of its customers&#59; the impact of a disruption in its global supply chain or important facilities&#59; ability to service its debt obligations&#59; its ability to comply with the US Foreign Corrupt Practices Act of 1977 and other applicable anti-corruption laws, particularly given that it has entered into a three-year Deferred Prosecution Agreement with the US Department of Justice&#59; uncertainty and impact relating to the potential phasing out of LIBOR and transition to alternative reference rates&#59; the need for additional financing through the issuance of debt or equity&#59; its reliance on outsourcing key business functions&#59; and intellectual property, including its ability to protect and maintain intellectual property&#59; the impact on unauthorized importation of its products from countries with lower prices to countries with higher prices&#59; uncertainties regarding the success of Alcon's separation and Spin-off from Novartis and the subsequent transformation program, including the expected separation and transformation costs, as well as any potential savings, incurred or realized by Alcon&#59; the effects of litigation, including product liability lawsuits and government investigations&#59; its ability to comply with all laws to which it may be subject&#59; effect of product recalls or voluntary market withdrawals&#59; the implementation of its enterprise resource planning system&#59; its ability to attract and retain qualified personnel&#59; the accuracy of its accounting estimates and assumptions, including pension plan obligations and the carrying value of intangible assets&#59; the ability to obtain regulatory clearance and approval of its products as well as compliance with any post-approval obligations, including quality control of its manufacturing&#59; legislative and regulatory reform&#59; the ability of Alcon Pharmaceuticals Ltd. to comply with its investment tax incentive agreement with the Swiss State Secretariat for Economic Affairs in Switzerland and the Canton of Fribourg, Switzerland&#59; its ability to manage environmental, social and governance matters to the satisfaction of its many stakeholders, some of which may have competing interests&#59; its ability to operate as a stand-alone company&#59; whether the transitional services Novartis has agreed to provide Alcon are sufficient&#59; the impact of the spin-off from Novartis on Alcon's shareholder base&#59; the impact of being listed on two stock exchanges&#59; the ability to declare and pay dividends&#59; the different rights afforded to its shareholders as a Swiss corporation compared to a US corporation&#59; and the effect of maintaining or losing its foreign private issuer status under US securities laws that it owns. Additional factors are discussed in Alcon&#8217;s filings with the United States Securities and Exchange Commission, including its Form 20-F. Should one or more of these uncertainties or risks materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated. Therefore, you should not rely on any of these forward-looking statements.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:132%">2&#47;3</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements in this press release speak only as of the date of its filing, and Alcon assumes no obligation to update forward-looking statements as a result of new information, future events or otherwise.</font></div><div style="padding-right:-15.4pt;text-align:justify"><font><br></font></div><div style="padding-right:-15.4pt;text-align:justify"><font><br></font></div><div style="padding-right:-15.4pt;text-align:justify"><font style="color:#003595;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">About Alcon</font></div><div style="padding-right:-15.4pt"><font style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people&#8217;s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 23,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at&#160;www.alcon.com.</font></div><div style="padding-right:-15.4pt"><font><br></font></div><div style="padding-right:13.7pt;text-align:justify"><font><br></font></div><div style="padding-right:13.7pt;text-align:justify"><font style="color:#1f497d;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Connect with us on</font></div><div style="padding-right:13.7pt"><font><br></font></div><div style="padding-right:13.7pt"><font style="color:#1f497d;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><img alt="alcon2q19pressrelease_imaga.gif" src="alcon2q19pressrelease_imaga.gif" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:37px"><font style="color:#003493;font-family:'Open Sans',sans-serif;font-size:9pt;font-weight:700;line-height:120%">    </font><img alt="alcon2q19pressrelease_imag.gif" src="alcon2q19pressrelease_imag.gif" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:41px"></div><div style="margin-top:8pt;padding-left:6.75pt;padding-right:6.75pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:6.75pt;padding-right:6.75pt;text-align:center"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.306%"><div style="margin-top:3pt;padding-right:13.5pt"><font style="color:#00aeef;font-family:'Open Sans',sans-serif;font-size:9pt;font-weight:700;line-height:144%;text-decoration:underline">Investor Relations</font></div><div style="padding-right:13.5pt"><font style="color:#221f1f;font-family:'Open Sans',sans-serif;font-size:9pt;font-weight:400;line-height:144%">Christina Cheng</font></div><div style="padding-right:13.5pt"><font style="color:#221f1f;font-family:'Open Sans',sans-serif;font-size:9pt;font-weight:400;line-height:144%">+ 41 589 112 110 (Geneva)</font></div><div style="padding-right:13.5pt"><font style="color:#221f1f;font-family:'Open Sans',sans-serif;font-size:9pt;font-weight:400;line-height:144%">+ 1 817 615 2789 (Fort Worth)</font></div><div style="padding-right:13.5pt"><font style="color:#0094ff;font-family:'Open Sans',sans-serif;font-size:9pt;font-weight:400;line-height:144%;text-decoration:underline">investor.relations&#64;alcon.com</font></div></div><div style="display:inline-block;max-width:7.386%;min-width:6.386%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.308%"><div style="padding-right:13.5pt"><font style="color:#00aeef;font-family:'Open Sans',sans-serif;font-size:9pt;font-weight:700;line-height:144%;text-decoration:underline">Media Relations</font></div><div style="padding-right:13.5pt"><font style="color:#221f1f;font-family:'Open Sans',sans-serif;font-size:9pt;font-weight:400;line-height:144%">Wes Warnock</font></div><div><font style="color:#221f1f;font-family:'Open Sans',sans-serif;font-size:9pt;font-weight:400;line-height:144%">+ 41 589 112 111 (Geneva)</font></div><div style="padding-right:13.5pt"><font style="color:#221f1f;font-family:'Open Sans',sans-serif;font-size:9pt;font-weight:400;line-height:144%">+ 1 817 615 2501 (Fort Worth)</font></div><div style="padding-right:13.5pt"><font style="color:#0094ff;font-family:'Open Sans',sans-serif;font-size:9pt;font-weight:400;line-height:144%;text-decoration:underline">globalmedia.relations&#64;alcon.com</font></div></div></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:132%">3&#47;3</font></div><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>alcon2q19pressrelease_imag.gif
<TEXT>
begin 644 alcon2q19pressrelease_imag.gif
M1TE&.#EABP"  /0       !WM1" NB"(OC"1PT"9R%"BS&"JT7"SUH"[VI#$
MWZ#,X[#5Z,#=[=#F\>#N]O#W^____P
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EKDLC'-4DQCGZ$(5V--P;\Y@VA/$12@7[8Q8#)C!! C!? 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>alcon2q19pressrelease_imaga.gif
<TEXT>
begin 644 alcon2q19pressrelease_imaga.gif
M1TE&.#EA2 !( /(      $)GLDYQMUIZO'&-Q7V7RO___P   "'Y! $
M+     !( $@ 0@C_  $(#$"PH,&#"!,J7,BPH4  #2-*G$BQHL6)  QHW,BQ
M8\>+("-F],@QI$F0(TD:@'BRY4&5,&-N9.G294J2-&OJ1'C38\Z=0 /T[/@S
MJ-&C2!T.A9FTX@"9,IM27#I3:D6H6#T2L&J0@->O7ZEJ! "VK "N$L6N1'M2
M;5&V4V.^G0K7Z-RZ>(^6]7HV;T,!:E7ZY9F5Y&"#@0'T/<S0+>.T<A\7+$SY
M[E'*A>MBQFH9KF/)C2.#7OAY=,+2I@^B3EUPM<7..EU/A<T:<>W;N'/KEDQ
MH$S:< %C-AU8L&3AFPV +L[T<0&H O=ZE1RX@&[9J;$3%YU;.]Z'X!_*0@U/
M'FYRJ-;9GI>YF.MZF,!WOE<97^=\DENI<\?M??G^V_WI!]]N 3Y6(&,''I;@
58 OZU6!>#]IF580$@2=5A \%!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>logopressrelease2a011.jpg
<TEXT>
begin 644 logopressrelease2a011.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1V<17AI9@  34T *@    @ "  +  (
M   F   (>@$2  ,    !  $   $Q  (    F   (H $R  (    4   (Q@$[
M  (    1   (VH=I  0    !   ([)R=  $    B   1<.H<  <   @,
M;@  $9(<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                     %=I;F1O
M=W,@4&AO=&\@161I=&]R(#$P+C N,3 P,3$N,38S.#0 5VEN9&]W<R!0:&]T
M;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X-  R,#$Y.C X.C$W(#$R.C$Q.C0Q
M $-H96YG+"!#:')I<W1I;F$    &D ,  @   !0  !%&D 0  @   !0  !%:
MDI$  @    ,R,P  DI(  @    ,R,P  H $  P    $  0  ZAP !P  " P
M  DZ     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                        ,C Q
M.3HP.#HQ-R Q,3HU-CHP-P R,#$Y.C X.C$W(#$Q.C4V.C W    0P!H &4
M;@!G "P ( !# &@ <@!I ', = !I &X 80     & 0,  P    $ !@   1H
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MC0 HHHHT ****- "BBBC0 HHHHT ****- "BBBC0 HHHHT ****- "BBBC0
MHHHHT ****- "BBBC0 HHHHT ****- "BBBC0 HHHHT ****- "BBBC0 HHH
MHT ****- "BBBC0 HHHHT ****- "BBBC0 HHHHT ****- "BBBC0 HHHHT
M****- "BBBC0 HHHHT ****- "BBBC0 HHHHT ****- "BBBC0 HHHHT ***
M*- "BBBC0 HHHHT ****- "BBBC0 HHHHT ****- "BBBC0 HHHHT ****0!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%=?H_P '/'_B#38-0TOP/XCU/3[A=T5W9:1<2Q.H;&X2*I4Y]C6-
M2M3HV]I*URHQE*]D<A16QXF\&^(/!=U';^(-"U30IYH_,BCU*SD@++D@MAU!
MP"/TK'K2,XSBI1=TQ--;A16MX;\):[XROFLM!T:_UN]5/,-OI]J\[A0<%L)G
MY<D<^];>J?!CX@Z%I]Q?ZEX%\2:?I]NGF375UI$\44:CJ6D90NWWS6<J]*$E
M&4DF_P!2E"4E=(XZBBBM^MB HHHI M0HHHIZ %%%%( HHHHT **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBF!TWPR\"WO
MQ.\?:#X6T\?Z5JMTD 91GRT/+N?95RWT4U^WGAOPQ8>%_#VFZ-I\ @L=/MTM
MK>->-B*NT =^G?J:^!?^"9?PE-]KFO?$&\@S%9K_ &;8,PX,C@-*R_[J;%_[
M:,*^M?VA?CUI_P "M)\.7=YY<AU;6+>Q96/,=L3NGE_X @_\>6OS7/:\\5BU
MAZ>R/HL%!4Z3G/J>-_\ !1SX0CQA\*(/%]G;K)J7AF7=,VT%FM)"HDY]$;8_
M^Z'K\QJ_>37-%L?%6@WVF7T27&GW]O);RQ]0\;J5(_%37XB?%+P#>?"_XB>(
M?"U[N:;2[MX1(PQYD8Y1A[,N#^->KPYBN:$L-/IL<F/HVDIK9GT;_P $S5#?
M'[4^!G_A'YQZ=)[<5]V?M4JJ_LY_$)@,-_8\_(Z_=KX4_P""9W_)?M3_ .P!
M<?\ H^"ONS]JK_DW'XA_]@>?_P!!KR\VO_:D?^W3JPEOJS9^+E#9& ?EST)K
MT[]GWX"ZY^T#XW&AZ21;6=NGG:AJ4@^2VCW8S_M.3]T=^?0U^FOPY_8O^$WP
M]TV*%?"MKKUV%Q)?:S&MS)*?4J<H/^ J*^HQV<TL!^[>LCS*6%G65UH?CYRS
M%1R1U Z_RHK]C?'G['WPE\?:6]O=>#K#3)V3$=UH\:VDL9_O#8 I/7AE(K\R
M/%WP'N8?CS=?#7P;J<7BVX%W]FBNH5V"/(!(E/(79R"PXX-&!SJCC(M-6:W"
MMA*E*W6YY5QU.!]2 I_$D4 ?,JG[Q&0.A_+FOU8^#7[!'P[^'FG6\GB#3X_&
M6O[=TUSJ +6Z-_=2#. O^]N/O7I>O?LN?"?Q/ISV=WX T..)QMW6EFMM(![/
M&%;]:\^IQ)0C4M"+:.E9?-JY^+=#97&< 'H>G]:^I?VNOV,Y_@;$/$WAF2?4
M?!\LBQS+,P:>PD8X4,0/F0M\JMU#%0>H+=I_P3Y^!?@3XN^&/%]SXN\/0:S-
M9WD,4#22R1[%9"2,(PSR!UKUY9M06%^M+5?CJ<2PTW4]GU/B8,.1U(.#W_K0
MS!>"<-TQD=?I7ZS^*OV"_A)KUUI1MM"_LBWM+@S7$-I/+FZ7:0L3.S'8-Q4D
MK\QQP:[V+]E[X26^E_V?'\/M ^S[=GS6*F3;_OGYL_C7D2XEH63C!_A_F=W]
MG3/Q;W ].G\J*^K_ -MK]DVQ^"<UGXJ\)K(OA?4)OLLUG,Y<V<Y!,85B2Q1@
M&ZDD;>3R*^4*^DPF+IXRFJM/9NQYE6E*C+ED%%%%=AD%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>GFKYLSBU_=.;"Q<<-*YY;_P3D\&6>A_L_Q:S'&OVS6[Z>:64_>VQNT,:^P
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M@X;UPLO\1Q9C?V@4445]:>4%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3CTS25K@\%2P5-PI=7<BK5E6=Y!1117<8A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/\C./UH'/M2"XE%%%,84444@>FX4444!N%%%% !1110 4444 %%%% !1110
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MQZ[I57^0J_;_  <\)VZX:PDE;UDNG_H:[?</4T<CJ"/R']:OEBMSD>:8R?\
MR\9S$/PS\*0-E=$MR?\ :W-_,U?B\%Z!"NU-%L0/>W4_TK9P<_=Q_GZ4X1O_
M '&/X'^F:7N+<QEBL7/_ )>2,^/1=.A^YI]HGT@3_"K:1I']Q%3_ '5 J:.U
MFF_U<;,/]D$_TK0@\+:Q<?ZG2KR;_KG S?T%2ZE-;M$>SQ53I+\3,5BOW3M^
MG%)]./IQ720_#?Q5<?ZOPWJI_P"W&4?S6KL/P?\ &=QT\.7Z_P"]"5_G7,\;
MAEO47WFWU/'2VIR_$X[)]3^='U.?KS7H$?P!\?R?=\.3?C)&/YM5V/\ 9O\
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M^M>T:;^RCXSO/FG;3[1?[KW#,W_CJ$5U>F?L=2R8>\\2QA?[EO:D_P#CQ?\
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M/3I\,Y53VHH\?M?V7_ =O_K;">?_ *Z7;C_T$BMNT^ /@.S^YX>A;_KH[O\
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M[3B<'??!7PM>?-'#<6C_ /3&X+?^A9KG[[]GNW;FQUB13_=FAW_^@XKUOG.
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M'\Z]>TK]GVXD"R:AJT:+_P \[1"__CYX_2NNTOX.>%]-^9[:6_D_OW4N/T7
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M2>3S]>:^LM6_9#T&Z5CINK7UDYZ+,%E4?A@']:X'6OV1_$UCN;3]0LM01?\
MGH6B8_\  2"/_'J]JCQ#@*WV[>J/F<1PKFV'^Q?T/"O?OZ]Z;<0I>1[)T6>/
M^Y*-R_D:[G6O@MXTT/=]H\/W;J/XK=1*/_'=U<?<V<]I,8IX9()5^\CJ01^!
M _G7LT\50K?PYIGS]3"XG#?%&4?O.3U+X:^&M6'[_1K=3_>@!C_]!(KE-4^
M6DW6Y[#4+JS]/,"RI^G->I<L,]O51D?SIN!Z9/K75[-=$:T<TQ>'_AS9X'JG
MP'U^SRUI<V=\GU,3?KFN2U3P3KVC,PN])NHU_OJN\?I7U3P.@Q3MQVD9./3M
M62IQ?PZGO4>)L7#^)%2/CDC;D' 8=0>/T.#0.?8^E?6>I^&-(UD'[;IMM<D]
M6>(;OSZUQVJ? _P[??/;"ZT]_6.8.GY-DUFZ;1[^'XHH5/=JKE/GRBO5-4^
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M(_\ OHX7_P >II7,*E:G15ZDK&12M\O4;?\ >&/ZUZMH7P#O;C:VJZA';?\
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ME&BE!X!X(/1LY%)2:L>@KM7044446%>^P4444AA1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>6APG^^3POXD5TSJ0HQYIM)'X-&G5Q4_<3E+MN8P^7IP?I3XH7FD"1QM(S'
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M5%Q<E+1'>45Y?XL^/.C>#]$\/ZI=V>I30:Y#Y]N((48QKM1OG^?C[Z_=W5S
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MA\WEL?+A!]E')_$U[/I>CV6BV:6UC:0V=O']R*$!5'T &*T5B55"J-J@8 '
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M.BF4@LX]\,/RJ7P#_P G6ZC_ -?U]_Z#)3OVC-+O?!WQ6TKQA;IO@D\B4/\
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MT/Y$9-CX;TS2])_LRTLHK:PV&/R(5V+M(P>GM7!_\,V_#MNN@D^QO+@]\_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
*HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
